PRESS RELEASES (selected)
Nascent Biotech, developer of Pritumumab (PTB), a monoclonal antibody shown promise in the treatment of brain cancer, has partnered with BioTools Inc (Jupiter, FL) to clearly define PTB’s higher order molecular structure (HOS) .
BioTools announces a collaboration with Schrödinger aimed at accelerating the discovery and development of chiral small molecule therapeutics
BioTools, Inc. co-founder and President receives University of Illinois Lifetime Achievement Award!
BioTools together with Ghent University and University of Antwerp are pleased to announce the formation of The European Centre for Chirality (EC2).
BioTools, Inc. celebrated its 10-year anniversary in 2010. From the start, we dared to be unique, innovative, and customer- driven and commercialized two groundbreaking techniques – VCD and ROA.